• Explore /
  • Poster
  • / A phase Ib study of nivolumab plus trastuzumab with S-1/capecitabine plus oxaliplatin for HER2 positive advanced gastric cancer (Ni-HIGH study).

A phase Ib study of nivolumab plus trastuzumab with S-1/capecitabine plus oxaliplatin for HER2 positive advanced gastric cancer (Ni-HIGH study).

Abstract Poster

Authors

null

Daisuke Takahari

Department of Gastroenterology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan

Daisuke Takahari , Takeru Wakatsuki , Naoki Ishizuka , Naoki Fukuda , Hirokazu Shoji , Hiroki Hara , Keiko Minashi , Narikazu Boku , Kensei Yamaguchi

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 Gastrointestinal Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session A: Cancers of the Esophagus and Stomach

Track

Cancers of the Esophagus and Stomach

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

UMIN000034222

Citation

J Clin Oncol 37, 2019 (suppl 4; abstr TPS177)

DOI

10.1200/JCO.2019.37.4_suppl.TPS177

Abstract #

TPS177

Poster Bd #

N9

Abstract Disclosures

Similar Posters

First Author: Daisuke Takahari

First Author: Yelena Y. Janjigian

First Author: Daisuke Takahari

First Author: Keun Wook Lee